Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
08/1997
08/26/1997US5661033 Gene transfer using herpes virus vectors as a tool for neuroprotection
08/26/1997US5661023 Ion exchanging and elution to recover retroviruses for vaccines
08/26/1997US5661022 Purification of retroviral vectors
08/26/1997US5661006 Polynucleotides genetic engineering a vaccines
08/26/1997US5660812 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
08/26/1997CA1339362C Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms
08/26/1997CA1339354C Recombinant retroviruses with amphotropic and ecotropic host ranges
08/26/1997CA1339346C Recombinant chimeric vaccine
08/21/1997WO1997030147A1 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same
08/21/1997WO1997029772A1 Recombinant canine herpesviruses
08/21/1997WO1997029766A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/21/1997CA2243662A1 Recombinant canine herpesviruses
08/21/1997CA2243562A1 Parasitic helminth larval thiol specific antioxidant proteins, nucleic acid molecules, and uses thereof
08/20/1997EP0789767A1 Purified papillomavirus proteins
08/20/1997EP0789766A1 Chimeric papillomavirus-like particles
08/20/1997EP0789592A1 Ocular gene therapy
08/20/1997EP0789575A1 Peripheral nervous system specific sodium channels, dna encoding therefor, crystallization, x-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
08/20/1997EP0789563A1 Hepatitis virus vaccines
08/19/1997US5658891 Oligonucleotide therapies for modulating the effects of herpesviruses
08/19/1997US5658785 Adeno-associated virus materials and methods
08/19/1997US5658779 Method of adsorbing viruses from fluid compositions
08/19/1997US5658776 Generation of high titers of recombinant AAV vectors
08/19/1997US5658727 Filamentous phage encapsulating genome encoding ligand-binding antibody comprising first and second polypeptides where first polypeptide is fused to carboxy terminal phage membrane anchor domain
08/19/1997US5658722 Irradiating a blood sampling mixed a radiation sensitizer
08/14/1997WO1997029195A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997WO1997029185A1 Recombinant phages
08/14/1997WO1997028822A1 Composition and method for causing photodynamic damage to target cells
08/14/1997WO1997028802A1 Inhibition of viral replication
08/14/1997CA2733866A1 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
08/14/1997CA2244848A1 Inhibition of viral replication
08/14/1997CA2244792A1 Recombinant phages
08/13/1997EP0789077A1 Viral material and nucleotide fragments associated with multiple sclerose having diagnostic, prophylactic and therapeutical uses
08/13/1997EP0788372A1 Attenuated canine parvovirus vaccine
08/12/1997US5656475 Use of lymphocytes transformed with herpesvirus saimiri in a process for replicating viruses of the HIV type which cause immune deficiency
08/12/1997US5656465 Methods of in vivo gene delivery
08/12/1997US5656275 Recombinant raccoon pox virus comprising the DNA encoding the nucleocapsid protein of feline infectious peritonitis virus
08/12/1997CA1339268C Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
08/12/1997CA1339267C Felv-infected feline cell line
08/07/1997WO1997028259A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same
08/07/1997WO1997027742A1 Method of protein production using mitochondrial translation system
08/07/1997CA2244709A1 Method of protein production using mitochondrial translation system
08/06/1997EP0787807A2 Primers and probes for hepatitis C detection
08/06/1997EP0787200A2 Improved adenovirus and methods of use thereof
08/06/1997EP0787199A1 Viable contaminant particle free adenoviruses, their preparation and use
08/06/1997EP0787198A1 Defective adenoviruses including a therapeutic gene and an immunoprotective gene
08/06/1997EP0787195A1 Production of peptides in plants as viral coat protein fusions
08/06/1997EP0787193A1 Method of producing a chimeric protein
08/06/1997EP0787191A2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
08/06/1997EP0787014A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation
08/06/1997EP0786989A1 Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
08/05/1997US5654195 Vectors expressing hybrid viruses, methods of use and novel assays
08/05/1997US5654185 Methods, compositions and apparatus for cell transfection
08/05/1997US5654138 Von hippel-lindau (VHL) disease gene and corresponding cDNA and methods for detecting carriers of the VHL disease gene
08/05/1997US5654136 Polypeptide
08/05/1997US5653976 Recombinant varicella-zoster virus and process for constructing same
07/1997
07/31/1997WO1997027311A1 Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv
07/31/1997WO1997027288A1 New attenuated strain of the virus causing the porcine reproductive respiratory syndrome (prrs), vaccines and diagnostic means obtainable with said strain, and production process
07/31/1997WO1997027213A1 Methods for screening for transdominant effector peptides and rna molecules
07/31/1997WO1997027212A1 Methods for screening for transdominant intracellular effector peptides and rna molecules
07/31/1997CA2244222A1 Methods for screening for transdominant effector peptides and rna molecules
07/31/1997CA2216436A1 New attenuated strain of the virus causing the porcine reproductive and respiratory syndrome (prrs), vaccines and diagnostic kits derived from the same, and procedures for the obtaining of the same
07/30/1997EP0786010A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins
07/30/1997EP0786003A1 Insect viruses and their uses in protecting plants
07/30/1997EP0785991A1 Preparation of rep-negative aav mutants and cells which can be used therefor
07/30/1997EP0785989A1 Microbial synthesis of hiv protease inhibitors
07/30/1997EP0785946A1 Materials for the production of nanometer structures and use thereof
07/30/1997EP0785786A1 Microbial synthesis of hiv protease inhibitors
07/29/1997US5652224 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
07/29/1997US5652130 Retroviral vectors expressing tumor necrosis factor (TNF)
07/29/1997US5652119 Recombinant feline herpesvirus vaccine
07/29/1997US5651972 Use of recombinant swine poxvirus as a live vaccine vector
07/24/1997WO1997026373A1 Isolation and propagation of a human herpesvirus derived from aids-associated kaposi's sarcoma cells
07/24/1997WO1997026337A1 Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions
07/23/1997EP0785255A2 Identification, purification and detection of WSBV (baculovirus associated with white spot syndrome)
07/23/1997EP0784693A1 Viral vectors and line for gene therapy
07/23/1997EP0784692A1 Attenuated viruses and method of making the same
07/23/1997EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating
07/23/1997EP0784685A2 Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
07/23/1997EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
07/23/1997EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
07/23/1997CN1155009A Determinating, purifying and testing for rhabdovirus of ichthyophthirius
07/22/1997US5650318 Process and culture medium for the production of cells infected by a multiple sclerosis-associated virus
07/22/1997US5650296 Expression of hepatitis B S and preS2 proteins in Pichia pastoris
07/22/1997US5650269 Method for detecting viral compounds using a β2'-glycoprotein I
07/22/1997US5650267 Proteins, polypeptides, nucleic acids and plasmids detected in solutions
07/22/1997US5650153 Genetic engineering, viruses and genomic dna
07/17/1997WO1997025446A1 Recombinase-mediated generation of adenoviral vectors
07/17/1997WO1997025415A1 Process for the deactivation of hiv and other viruses
07/17/1997CA2239366A1 Recombinase-mediated generation of adenoviral vectors
07/16/1997EP0783586A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus
07/16/1997EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE
07/16/1997EP0783567A1 Human galactokinase gene
07/16/1997CN1154718A Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression
07/15/1997US5648466 Method for detecting bovine diarrhoea virus infection, nucleotide sequence encoding a protein induced by this virus infection and recombinant proteins and antigens relating thereto
07/15/1997US5648459 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
07/15/1997US5648251 Method of transduction of cells with retroviral vectors
07/10/1997WO1997024461A1 Methods of culturing and assaying a virus
07/10/1997WO1997024452A2 Toxic-protein expressing viruses and producer cell lines
07/08/1997US5646034 Recombinant adeno-associated virus
07/08/1997US5646033 African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines